KCP
BSX icon

Kera Capital Partners’s Boston Scientific BSX Stock Holding History

Kera Capital Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,317
Closed -$208K – 641
2026
Q1 		$208K Sell
3,317
-1,708
-34% -$137K 0.03% 537
2025
Q4 		$470K Buy
5,025
+1,618
+47% +$159K 0.06% 266
2025
Q3 		$333K Buy
3,407
+109
+3% +$11.3K 0.05% 261
2025
Q2 		$354K Buy
+3,298
New +$334K 0.07% 149

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Kera Capital Partners's BSX Position: Q2 2026 in Review

Kera Capital Partners sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 3,317 shares — an estimated $208K sold.

Kera Capital Partners first reported a position in BSX in Q2 2025 and held it in 4 quarters. The position peaked at $470K in Q4 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Kera Capital Partners reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Kera Capital Partners sold 3,317 Boston Scientific shares in Q2 2026, an estimated $208K.
  • Kera Capital Partners first reported a position in Boston Scientific in Q2 2025 and held it in 4 quarters.
  • Kera Capital Partners's Boston Scientific position peaked at $470K in Q4 2025.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Kera Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.